RIXIMYO

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 45633d96aadf424a
Drug Approval Canada Name: RIXIMYO
Product Name: RIXIMYO
Status: Marketed
Status Date: 2020-05-22
Original Market Date: 2020-05-22
Din: 02498316
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 10:00.00
Atc Original: L01FA01 RITUXIMAB
Atc Name: l 01 fa 01
Aig Number: 0140241001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

RITUXIMAB

10 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

45633d96aadf424a

Type

Standard